Literature DB >> 33771848

Effectiveness of a Cancer Risk Prediction Tool on Lifestyle Habits: A Randomized Controlled Trial.

Keiichi Yuwaki1,2, Aya Kuchiba3, Aki Otsuki1, Miyuki Odawara4, Tsuyoshi Okuhara5, Hirono Ishikawa6, Manami Inoue1, Shoichiro Tsugane1, Taichi Shimazu7.   

Abstract

BACKGROUND: Risk prediction models offer a promising approach to lifestyle modification. We evaluated the effect of personalized advice based on cancer risk prediction in improving five lifestyle habits (smoking, alcohol consumption, salt intake, physical activity, and body mass index) compared with standard advice without risk prediction among a Japanese general population with at least one unhealthy lifestyle habit.
METHODS: In a parallel-design, single-blind, randomized controlled trial between February 2018 and July 2019, 5984 participants aged 40-64 years with unhealthy lifestyle habits were recruited from persons covered under a life insurance policy. They were randomly assigned to an intervention or control group and received personalized or standard advice, respectively. They were also sent an invitation to participate in a lifestyle modification program aimed at improving lifestyle. Primary outcome was an improvement in lifestyle, defined as an increase in healthy lifestyle habits within 6 months.
RESULTS: The proportion of participants who improved their lifestyle within 6 months in the intervention group did not significantly differ from that in the control group (18.4% vs. 17.7%; P = 0.488). Among participants with low health literacy and two or fewer of five healthy habits, the proportion of participants subscribing to the lifestyle modification program was higher in the intervention group than in the control group.
CONCLUSIONS: Compared with standardized advice, personalized advice based on cancer risk prediction had no effect on improving lifestyle. IMPACT: Provision of predicted cancer risk information did not induce change in unhealthy lifestyle. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 33771848     DOI: 10.1158/1055-9965.EPI-20-1499

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  1 in total

1.  A Machine-Learning-Based Risk-Prediction Tool for HIV and Sexually Transmitted Infections Acquisition over the Next 12 Months.

Authors:  Xianglong Xu; Zongyuan Ge; Eric P F Chow; Zhen Yu; David Lee; Jinrong Wu; Jason J Ong; Christopher K Fairley; Lei Zhang
Journal:  J Clin Med       Date:  2022-03-25       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.